184 related articles for article (PubMed ID: 352583)
1. Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE).
Morimoto C
Clin Exp Immunol; 1978 Apr; 32(1):125-33. PubMed ID: 352583
[TBL] [Abstract][Full Text] [Related]
2. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.
Delfraissy JF; Segond P; Galanaud P; Wallon C; Massias P; Dormont J
J Clin Invest; 1980 Jul; 66(1):141-8. PubMed ID: 6447163
[TBL] [Abstract][Full Text] [Related]
3. Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by nonsuppressor T cells.
Sakane T; Takada S; Suzuki N; Tsuchida T; Murakawa Y; Ueda Y
J Immunol; 1986 Dec; 137(12):3809-13. PubMed ID: 2946769
[TBL] [Abstract][Full Text] [Related]
4. Mononuclear phagocytes from patients with active systemic lupus erythematosus down-regulate the specific in vitro reactivity of autologous lymphocytes to double-stranded DNA.
Weill BJ; Renoux ML
Clin Exp Immunol; 1988 Apr; 72(1):43-9. PubMed ID: 3293851
[TBL] [Abstract][Full Text] [Related]
5. Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction.
Sagawa A; Abdou NI
J Clin Invest; 1978 Oct; 62(4):789-96. PubMed ID: 308952
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
Tsokos GC; Magrath IT; Balow JE
J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
[TBL] [Abstract][Full Text] [Related]
7. [Serum factors inhibiting cellular immunity in systemic lupus erythematosus].
Lavalle C; Alcocer J; Gudiño J; Fraga A
Prensa Med Mex; 1978; 43(1-2):16-20. PubMed ID: 309127
[TBL] [Abstract][Full Text] [Related]
8. Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction.
Sagawa A; Abdou NI
J Clin Invest; 1979 Mar; 63(3):536-9. PubMed ID: 311787
[TBL] [Abstract][Full Text] [Related]
9. Autologous rosette formation in systemic lupus erythematosus.
Bodolay E; Szegedi G
Acta Med Hung; 1983; 40(2-3):81-9. PubMed ID: 6608094
[TBL] [Abstract][Full Text] [Related]
10. Defective monocyte production of, and T lymphocyte response to, interleukin-1 in the peripheral blood of patients with systemic lupus erythematosus.
Alcocer-Varela J; Laffon A; Alarcón-Segovia D
Clin Exp Immunol; 1984 Jan; 55(1):125-32. PubMed ID: 6229371
[TBL] [Abstract][Full Text] [Related]
11. Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.
Bresnihan B; Jasin HE
J Clin Invest; 1977 Jan; 59(1):106-16. PubMed ID: 830659
[TBL] [Abstract][Full Text] [Related]
12. Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.
Sakane T; Steinberg AD; Reeves JP; Green I
J Clin Invest; 1979 May; 63(5):954-65. PubMed ID: 312810
[TBL] [Abstract][Full Text] [Related]
13. Normal T cell regulation of IgG synthesis in systemic lupus erythematosus.
Nies KM; Stevens RH; Louie JS
J Clin Lab Immunol; 1980 Sep; 4(2):69-75. PubMed ID: 6449594
[TBL] [Abstract][Full Text] [Related]
14. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
Kammer GM; Birch RE; Polmar SH
J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
[TBL] [Abstract][Full Text] [Related]
15. In vitro TNP-specific antibody formation by peripheral lymphocytes from patients with systemic lupus erythematosus.
Morimoto C; Abe T; Hara M; Homma M
Scand J Immunol; 1977; 6(6-7):575-9. PubMed ID: 333548
[TBL] [Abstract][Full Text] [Related]
16. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
[TBL] [Abstract][Full Text] [Related]
17. Antibody-dependent direct cytotoxicity of human lymphocytes. I. Studies on peripheral blood lymphocytes and sera of patients with systemic lupus erythematosus.
Scheinberg MA; Cathcart ES
Clin Exp Immunol; 1976 May; 24(2):317-22. PubMed ID: 1084243
[TBL] [Abstract][Full Text] [Related]
18. The role of nonactivated and interferon-gamma activated monocytes in regulating normal and SLE patient B cell responses to TNP-Brucella abortus.
Golding B; Tsokos GC; Fleisher T; Muchmore AV; Blaese RM
J Immunol; 1986 Jul; 137(1):103-7. PubMed ID: 3086443
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
Moutsopoulos HM; Fauci AS
J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
[TBL] [Abstract][Full Text] [Related]
20. Role of stimulated neutrophils from patients with systemic lupus erythematosus in disturbed immunoreactivity, with special reference to increased oxygen intermediates generated by the neutrophils.
Niwa Y; Sakane T; Shingu M; Yokoyama M
J Clin Lab Immunol; 1984 May; 14(1):35-43. PubMed ID: 6086929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
